Novo Nordisk A/S (NVO)
NYSE·Healthcare·Drug Manufacturers - General
$44.33
+1.78%
Mkt Cap $176.82B
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$47.00
Range $42.00 – $54.00
Implied Upside
+6.0%
Consensus $47.00 vs current $44.33
NYSE·Healthcare·Drug Manufacturers - General
$44.33
+1.78%
Mkt Cap $176.82B
No recent rating data.
Price Target (16 analysts)
$47.00
Range $42.00 – $54.00
+6.0%
Consensus $47.00 vs current $44.33